Scrip is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Insulet Corporation

https://www.insulet.com/

Latest From Insulet Corporation

Exec Chat: How Glooko Plans To Ride Digital Health Care Wave To Profitability

In an interview with Medtech Insight, Glooko CEO Russ Johannesson outlines the company’s growth opportunities, expansion plans beyond diabetes and financing plans.

Exec Chat Diabetic Care

Lilly Tries New Neuro Approach With Disarm Buyout

Deal Snapshot: Lilly bets $135m on biotech’s preclinical SARM1 inhibitor program, seeing potential in peripheral neuropathy and possibly some bigger targets in neurology like MS and ALS.

M & A Deals

Insulin Pump Market Heats Up Among Rivals Medtronic, Insulet and Tandem

Three major insulin pump developers are gearing up to introduce next-generation devices over the coming year, but COVID-19 continues to create uncertainties.

Diabetic Care Financing

Roche Partners With UCB On Anti-Tau Alzheimer’s Drug

UCB gets $120m up front from Roche for option rights to UCB0107 and retains full rights to the drug in progressive supranuclear palsy.

Deals Business Strategies
See All

Company Information

  • Industry
  • Medical Devices
  • Other Names / Subsidiaries
    • Insulet Canada Corporation
    • Neighborhood Diabetes
    • Neighborhood Holdings, Inc.
UsernamePublicRestriction

Register